MacroGenics Inc (NASDAQ:MGNX)
| 3.55 BATS BZX Real-Time Price As of 11:16am ET |  -0.02 / -0.56%Today’s Change | 3.48 Today|||52-Week Range 32.81 | -77.88% Year-to-Date |
Latest MGNX News | Press Releases
No recent news for MacroGenics Inc.
Today’s Trading
| Previous close | 3.57 |
| Today’s open | 3.58 |
| Day’s range | 3.48 - 3.63 |
| Volume | 13,012 |
| Average volume (3 months) | 704,760 |
| Market cap | $244.4M |
Data as of 11:16am ET, 05/26/2022
Growth & Valuation
| Earnings growth (last year) | -36.29% |
| Earnings growth (this year) | -1.50% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -26.16% |
| P/E ratio | NM |
| Price/Sales | 12.42 |
| Price/Book | 1.02 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| GSGTFGensight Biologics S... | 0.00 | 0.00% |
| ZOMZomedica Corp | +0.01 | +2.75% |
| ---- | ||
| STROSutro Biopharma Inc | +0.07 | +1.58% |
Data as of 11:17am ET, 05/26/2022
Financials
| Next reporting date | August 3, 2022 |
| EPS forecast (this quarter) | -$0.96 |
| Annual revenue (last year) | $77.4M |
| Annual profit (last year) | -$202.1M |
| Net profit margin | -260.97% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Rockville, Maryland |
Forecasts
